Treatment of chronic hepatitis C in haemophilic patients with interferon and ribavirin: a meta-analysis | Zendy

Massimo Franchini | Zendy; Carlo Mengoli | Zendy; Dino Veneri | Zendy; Romualdo Mazzi | Zendy; Giuseppe Lippi | Zendy; Mario Cruciani | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treatment of chronic hepatitis C in haemophilic patients with interferon and ribavirin: a meta-analysis

Author(s) -

Massimo Franchini,

Carlo Mengoli,

Dino Veneri,

Romualdo Mazzi,

Giuseppe Lippi,

Mario Cruciani

Publication year - 2008

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkn119

Subject(s) - ribavirin , medicine , chronic hepatitis , interferon , hepatitis c , virology , meta analysis , gastroenterology , virus

Hepatitis C virus (HCV) infection is a major cause of morbidity and mortality among haemophilic patients who were treated with clotting factor concentrates before the availability of virus-inactivated factors in the mid 1980s. In order to analyse the effect of the current combination anti-HCV treatment [i.e. ribavirin plus interferon (IFN)] in this subset of HCV-infected patients, we performed a systematic review with meta-analysis of the available literature.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research